This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Forschungsverbund Berlin E.v., Max-Delbrueck-Centrum Fuer Molekulare Medizin, Pharmos Bioscience A/s. Active years: 2010-2018.
Company Filing History:
1 out of 93 
1 out of 18 
1 out of 1 Years Active: 2010-2018
Title: Thomas Jentsch: Innovator in Protein Complexes and Channel Modulators
Introduction
Thomas Jentsch is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of molecular medicine, particularly in the study of LRRC8 proteins and chloride channels. With a total of 2 patents, his work has implications for various medical conditions, including osteoporosis.
Latest Patents
Jentsch's latest patents focus on two key inventions. The first patent involves LRRC8 proteins and protein complexes, detailing a method for identifying channel modulators that interact with LRRC8A, LRRC8B, LRRC8C, LRRC8D, and/or LRRC8E. This invention also includes isolated heteromeric protein complexes for use in identifying VRAC (VSOAC) modulators. The second patent describes a method for screening compounds that modulate the activity of the chloride channel ClC-7. This method assesses whether a test compound inhibits the binding of Ostm1 to ClC-7, with potential applications in treating bone resorption conditions.
Career Highlights
Throughout his career, Thomas Jentsch has worked with notable institutions, including the Forschungsverbund Berlin e.V. and the Max-Delbrück-Centrum für Molekulare Medizin. His research has significantly advanced the understanding of ion transport and its implications for health.
Collaborations
Jentsch has collaborated with esteemed colleagues, including Tobias Stauber and Philipp Lange. Their joint efforts have contributed to the advancement of research in protein complexes and channel modulation.
Conclusion
Thomas Jentsch's innovative work in the field of protein complexes and channel modulators has the potential to impact medical treatments significantly. His contributions continue to shape the landscape of molecular medicine.